[The laboratory diagnostic in patients with mucoviscidosis: A review.]

The mycobacterioses as a group of diseases conditioned by non-tuberculosis mycobacteria, acquire even greater significance for patients from various risk groups. The patients with cystic fibrosis along with patients with other genetic diseases, consist risk group of infection with non-tuberculosis mycobacteria. The diagnostic of mycobacterioses in patients with cystic fibrosis has a number of peculiarities both at the stage of processing clinical material and the stage of identification of separated microorganisms. The review presents modern data about possibilities of laboratory diagnostic of with regard to characteristics of epidemiology, risk factors, contamination screening, material decontamination, methods of cultivation and identification of non-tuberculosis mycobacteria in patients with cystic fibrosis. The data is presented concerning increasing of morbidity of mycobacterioses up to 6-13% among patients with cystic fibrosis in developed countries. The low level of prevalence of mycobacterioses among patients with cystic fibrosis in the Russian Federation is demonstrated. The risk factors of development of mycobacterioses from point of view of contamination with various microorganisms, particularly with fungi of species Aspergillus are described. The technique of two-stage decontamination of phlegm and possible limitations of its cultivation in automated systems and possibilities of using 1% solution of chlorhexidine and sodium dodecyl sulfate for decontamination are described. Besides standard techniques, a technique of separation of mycobacteria is presented based on inoculation of material on medium for selective separation of Burkholderia cepacia complex. The possibilities of identification of mycobacteria using MALDIToF mass-spectrometry. The review was based on sources from such international and national data bases as Scopus, Web of Science, RINC.